ClinicalTrials.gov
public full text
Public Domain
A Long-term Trial of EB-1020 in Pediatric Patients With ADHD
The purpose of this study is to evaluate the safety of long-term administration of mainly high doses of EB-1020 over 52 weeks in pediatric ADHD patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease#1033608
- Software Treatment for Actively Reducing Severity of ADHD in Adults (STARS ADHD Adult)#875729
- Safety and Feasibility of Temporal Interference Brain Stimulation for Treatment in Psychiatric Disorders#826805
- Effectiveness of a 6-week Hippotherapy Program in Children With Autism Spectrum Disorder#1086586
- Safety and short-term outcomes of lecanemab for Alzheimer's disease in China: a multicentre study.#260287
Record · ID 981246
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive